EUROPE: Targeted smart medicine capsules developed by EU scientists
February 1st, 2009
By Monica Dobie
A European Union (EU)-funded research project called SonoDrugs is developing tiny, image-guided medicine capsules conveying doses through blood vessels to the centre of an infection or disease, after which the drugs are activated by ultrasound pulses. This new technology is initially being developed for cardiovascular disease and cancer by the Euro 15.9 million project, which includes Dutch electronics giant Philips; Nanobiotix, of France; and Lipoid, of Germany; as well as academics from the University of Cyprus, University of Gent (Belgium), ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.